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Secular trends in self reported sexual activity and
satisfaction in Swedish 70 year olds: cross sectional survey
of four populations, 1971-2001
Nils Beckman, Margda Waern, Deborah Gustafson, Ingmar Skoog
ABSTRACT
Objective To study secular trends in self reported sexual
behaviour among 70 year olds.
Design Cross sectional survey.
Settings Four samples representative of the general
population in Gothenburg, Sweden.
Participants 1506 adults (946 women, 560 men)
examined in 1971-2, 1976-7, 1992-3, and 2000-1.
Main outcome measures Sexual intercourse, attitudes to
sexuality in later life, sexual dysfunctions, and marital
satisfaction.
Results From 1971 to 2000 the proportion of 70 year olds
reporting sexual intercourse increased among all groups:
marriedmen from52% to 68% (P=0.002),marriedwomen
from 38% to 56% (P=0.001), unmarried men from 30% to
54% (P=0.016), and unmarried women from 0.8% to 12%
(P<0.001). Men and women from later birth cohorts
reported higher satisfaction with sexuality, fewer sexual
dysfunctions, and more positive attitudes to sexuality in
later life than those from earlier birth cohorts. A larger
proportionofmen (57% v40%,P<0.001)andwomen (52%
v 35%, P<0.001) reported very happy relationships in
2000-1 compared with those in 1971-2. Sexual debut
beforeage20 increased inboth sexes: inmen from52%to
77% (P<0.001) and in women from19% to 64% (P<0.001).
Conclusion Self reported quantity and quality of sexual
experiences among Swedish 70 year olds has improved
over a 30 year period.
INTRODUCTION
Most elderly participants in surveys on sexual beha-
viour developed their views during the early part of the
20th century. We examined secular trends in sexual
behaviour and attitudes to sexuality in later life in
70 year olds from Gothenburg, Sweden.
METHODS
Sample populations
Four representative samples of 70 year olds from
Gothenburg were surveyed in 1976-7, 1992-3, and
2000-1, to study secular trends in health. The samples
were obtained from the Swedish population register.
No significant differences existed between responders
and non-responders (see bmj.com).12
Sample 1—participants born between 1 July 1901 and
30 June 1902 on dates ending with 2, 5, or 8 were
invited to a health examination in 1971-23; 392 of 460
(85.2%) participated in a psychiatric examination.1
Sample 2—participants born between 1 July 1906 and
30 June 1907 on dates ending with 2, 5, or 8 were
invited to a health examination in 1976-7; 404 of 513
(78.8%) participated in a psychiatric examination.2
Sample 3—70yearoldwomenborn in1922ondays6,
12, 18, 24, or 30were invited to a health examination in
1992-3; 249 of 381 (65.4%) participated in a psychiatric
examination.
Sample 4—70 year olds born in 1930 on days 3, 6, 12,
18, 21, 24, or 30were invited to a health examination in
2000-1; 500 of 767 (65.2%) participated in a psychiatric
examination.
The psychiatric examination included questions on
sexual behaviour: attitudes to sexuality in later life,
frequency of intercourse during the past year, and age
of sexual debut and its timing in relation to marriage.
Sexual activity was defined as having had intercourse
during the past year. Intercourse was defined as sexual
contact, most often with penetration. Questions asked
in the examinations of all but the first sample were
about whether sexuality was a positive or negative
factor in life, satisfaction with intercourse, sexual
dysfunction, and reason for cessation of intercourse.
One of the researchers (IS), a psychiatrist, was trained
by those who did the examinations in the 1970s, and
trained those who did the examinations in 1992 and
2000. Inter-rater agreement on frequency of intercourse
and attitudes to sexuality at age 70 were high.
Statistical analysis
We categorised marital status as married or cohabiting
compared with unmarried. Educational level was
dichotomised as compulsory or more than compulsory.
Differences in proportionswere tested using Fisher’s
exact test. The Cochran-Armitage χ2 test was used to
test for trends.Weused an asymptotic permutation test
of trend for differences in the median age of sexual
debut. Data were analysed by strata of sex and marital
status. For regression analyses we also pooled data
fromall the samples.Weusedbinary logistic regression
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models to estimate the odds of reporting intercourse
(yes or no within the past year) by sample (1971-2 plus
1976-7 v 1992-3 plus 2000-1), marital status, male
gender, sexual debut before age 20, a positive attitude
towards sexuality in later life, diagnosis of depression,
educational level, and three yearmortality.Wepresent
the associations as odds ratios and 95% confidence
intervals. In all analyses we used two tailed tests. We
considered results significant at P<0.05.
RESULTS
Among both sexes the proportion of participants who
were divorced, cohabiting, or in a relationship but
livingapart increasedover the30years of sampling (see
bmj.com). Among those who had a partner, the
proportion reporting a happy relationship increased
in both sexes. Compared with men, women in all
samples were less often married or cohabiting, more
often widowed, and more often had an older partner.
The proportion of 70 year olds reporting that they
were sexually active, that sexuality had been a positive
factor in their life, and that had a positive attitude to
sexuality in later life increased during the study period,
both among married and cohabiting participants and
among unmarried participants (table). Fewer people in
later cohorts reported never having had intercourse.
Among those reporting intercourse, the proportion
that had intercourse at least once aweek increased over
the 30 year period. Concurrently the reported median
age of sexual debut decreased in both sexes and the
proportion reporting premarital intercourse increased
in women. Reported intercourse was more common
among men than among women in all four samples,
and men reported an earlier age of sexual debut than
women although the differences between the sexes for
this variable diminished among those from later born
samples.
In a logistic regression analysis including the entire
sample, being in a later born cohort increased the odds
of having intercourse (odds ratio 1.48, 95% confidence
interval 1.10 to 2.00), independent of marital status,
sex, sexual debut before age 20, a positive attitude to
sexuality in later life, depression, educational level, and
three year mortality.
The proportion of women reporting high or very
high sexual satisfaction increased and reports of no
sexual satisfactiondecreased from the second to the last
samples (see bmj.com).
Among thosewhohadapartner, both sexes reported
that in most cases cessation of intercourse was due to
male related factors (see bmj.com).This pattern did not
change over the 30 year period.
DISCUSSION
Self reported sexual activity among 70 year olds in
Gothenburg, Sweden increased from 1971 to 2001. At
the same time among elderly people attitudes to
sexuality became more positive, and the proportion
reporting a veryhappy relationship increased. Further-
more, the proportion reporting high satisfaction with
sexual activity and that sexuality was an important
factor in life increased. Consistent with population
studies of younger samples of later born cohorts4-6 the
median age of sexual debut decreased and the
proportion that had their sexual debut before age 20
increased. The one year prevalence of intercourse in
the two earliest birth cohorts was similar to that among
septuagenarians reported fromstudies in the 1950s and
Self reported sexual behaviour and attitudes in four samples of 70 year olds from Gothenburg, Sweden, examined in 1971-2, 1976-7, 1992-3, and 2000-1.
Values are number who answered question of total number examined (percentage) unless stated otherwise
Variable
Men Women
1971-2
(n=161)
1976-7
(n=174)
2000
(n=225)
Sample
trend P
value†
1971-2
(n=221)
1976-7
(n=222)
1992
(n=241)
2000
(n=262)
Sample
trend P
value†
Positive attitude towards
sexuality in old age
121/148 (82) 139/173 (80) 200/207 (97) 0 135/208 (65) 135/215 (63) 212/238 (89) 219/232 (94) 0
Married or cohabiting 97/117 (83) 106/133 (80) 162/168 (96) 0 62/89 (70)* 55/92 (60)** 119/135 (88) 109/117 (93) 0
Not married 24/31 (77) 33/40 (83) 38/39 (97) 0.010 73/119 (61) 80/123 (65)* 93/104 (89) 110/115 (96) 0
Sexuality a positive factor in life — 44/174 (26) 196/206 (95) 0‡ — 10/214 (5)*** 121/225 (54) 181/231 (78)*** 0
Sexual intercourse during past
year
72/152 (47) 83/173 (48) 133/203 (66) 35/209 (12) 39/213 (18) 81/232 (35) 77/225 (34)
Married or cohabiting 62/119 (52)* 71/133 (53)* 113/166 (68) 0.002 34/89 (38)*** 34/92 (37)*** 70/130 (54)*** 63/112 (56)*** 0
Not married 10/33 (30) 12/40 (30) 20/37 (54) 0.016 1/120 (1)*** 5/121 (4)*** 11/102 (11) 14/113 (12)*** 0
Sexual intercourse once weekly
or more among sexually active
7/72 (10) 22/83 (27) 41/133 (31) 0.006 3/35 (9) 7/39 (18) 16/81 (20) 20/77 (26) 0.047
Sexual debut before age 20
(median age at sexual debut)
77/148 (52)
(19.3)
94/167 (56)
(18.7)
159/207 (77)
(17.7)
0§ 39/203 (19)
(22.7)
57/206 (28)
(22.0)
112/230 (49)
(19.6)
147/229 (64)
(18.6)
0§
Sexual intercourse before
marriage
123/149 (83) 147/171 (86) 183/207 (88) 0.151 86/180 (48)*** 143/194 (74)** 172/229 (75) 198/226 (88) 0
Sexually inexperienced 1/156 (1) 0/173 (0) 0/207 (0) 0.308 23/210 (11)*** 15/212 (7)*** 1/231 (0.4) 1/229 (0.4) 0
Number of participants varies within cohorts as some declined to answer some questions.
*P<0.05; **P<0.01; ***P<0.001 (Fisher’s exact test) for difference between sexes in birth sample, or difference between participants who were married or cohabiting and not married.
†Cochran-Armitage χ2 test for sample trend.
‡Fisher’s exact test.
§Test for column trend with asymptotic permutation test of trends.
RESEARCH
152 BMJ | 19 JULY 2008 | VOLUME 337
1980s.7 8 The prevalence in the two younger birth
cohorts is similar to a European study in 2001-29 and a
US study in 2005-6.10
Whether elderly couples continue to be sexually
active seems toa largeextent tobedeterminedbymen.11
This pattern, which did not change over time, was also
reported in studies in the 1950s12 and in 2005-6.10
In agreement with previous reports self reported
sexual activitywasmore common inmen, regardless of
marital status.8-10 12-16 Differences between the sexes in
self reported sexual behaviour, however, decreased
from1971 to 2001 among the 70 year olds in our study.
Overall, men reported an earlier age of sexual debut
and a higher proportion of premarital sex than women
in the 1970s, but this sex difference diminished among
those in later born samples. Finally, whereas 70 year
old men in the 1970s more often reported positive
attitudes to sexuality than women, there were no sex
differences in attitudes in 2000-1. Thus attitudes to
sexuality cannot entirely explain observed differences
between the sexes in sexual activity. Women were less
likely to be married or in other intimate relationships
than men, as reported by others.10 As in other
studies,8 10 12 the proportion of elderly people reporting
sexual activity was higher amongmarried participants,
especially in women.
In 2000 around two thirds of adults reported high
sexual satisfaction, a substantial increase from 1976,
especially in women. The proportion of women who
reported no or low satisfaction decreased, whereas the
proportion of men with low satisfaction increased. It
could be speculated that it has become more permis-
sible formen to admit failure in sexualmatters or that a
real difference exists.
It was beyond the scope of this study to examine in
detail the reasons for self reported secular changes in
sexual behaviour over 30 years. It could be speculated
that the changes reflect higher educational levels and
better socioeconomic status in the later birth cohorts.
Furthermore, cohabitingand livingapart becamemore
common. The proportion never married decreased
and the proportion divorced increased in the later born
samples. These samples also experienced better gen-
eral health.17 When several of these factors were taken
into consideration ina logistic regressionanalysis, birth
year was still related to sexual activity, suggesting that
several unidentified factors might be important.
Changes in legislation may have influenced public
attitudes to sexuality during the 20th century. Sex
education became compulsory in schools in Sweden in
1955. By the end of the 1950s condoms were available
in vending machines in public places. The “sexual
revolution” followed in the 1960s, with the contra-
ceptive pill and intrauterine devices.18
Strengths and limitations
This study was based on four population samples
examined similarly over a 30 year period. The inter-
views were part of a comprehensive investigation on
ageing and thus people were not recruited explicitly to
talk about their sexuality.
This study had several limitations. Firstly, although
higher than in most studies on sexual behaviour, the
response rate declined from 80% to 65% during the
30 year period.No differenceswere identified between
responders andnon-responders for several factors.The
secular trends in reported sexual behaviour over the
study period were, however, pronounced. We cannot
exclude the possibility that non-responders had more
sexual problems than responders. Secondly, we
examined 70 year olds thus we cannot draw conclu-
sions on sexual behaviour before this age. Thirdly,
sexual behaviour is a sensitive matter to report.
Semistructured interviews were, however, done by
doctors or psychiatric research nurses. Fourthly, the
first three cohorts were examined by psychiatrists and
the fourth by nurses, but differences were not large.
Fifthly, changes in evaluations of responses over time
may have influenced the results. One researcher (IS)
was trained by those who carried out the examinations
in the 1970s, who in turn trained those doing the
examinations in 1992 and 2000. Inter-rater reliability
between the researcher and examiners in the 1970s and
1990s was high. Sixthly, the study is based on self
report, lending itself to reporting bias. More positive
attitudes to sexuality in 70 year olds in later born
cohorts might have resulted in more participants
reporting intercourse. It is possible that our results
reflect amore openminded attitude in society to sexual
matters rather than real changes in sexual behaviour.
Seventhly, the definition of sexual activity was limited
to intercourse between heterosexuals. Thus we cannot
generalise our results to other types of sexuality. As we
aimed to describe secular trends, we were limited to
those questions used in the 1970s. Finally, depression is
common in elderly people and is well known to affect
sexual activity. Our results for prevalence, however,
did not change when we excluded depressed partici-
pants, and year of birth was still related to sexual
activity in 70 year oldswhen depressionwas controlled
for in logistic regression analyses including all four
samples.
Conclusions
Self reported quantity and quality of sexual experi-
ences among 70 year olds improved over a 30 year
period. At the same time, a relatively large proportion
of participants had ceased having intercourse. Our
study, however, shows that most elderly people
WHAT IS ALREADY KNOWN ON THIS TOPIC
Secular trends in elderly people’s sexual behaviour is
unclear
WHAT THIS STUDY ADDS
The quantity and quality of sexual experiences among
70 year olds in Sweden improved over a 30 year period
Attitudes to sexuality have becomemore positive in this age
group
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consider sexual activity and associated feelings a
natural part of later life.
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Prognosis in patients with recent onset low back pain in
Australian primary care: inception cohort study
Nicholas Henschke,1,2 Christopher G Maher,1,2 Kathryn M Refshauge,2 Robert D Herbert,1,2
Robert G Cumming,3 Jane Bleasel,4 John York,4 Anurina Das,2 James H McAuley1,2
ABSTRACT
Objective To estimate the one year prognosis and identify
prognostic factors in cases of recent onset low back pain
managed in primary care.
Design Cohort study with one year follow-up.
Setting Primary care clinics in Sydney, Australia.
Participants An inception cohort of 973 consecutive
primary care patients (mean age 43.3, 54.8% men) with
non-specific low back pain of less than two weeks’
duration recruited from the clinics of 170 general
practitioners, physiotherapists, and chiropractors.
Main outcome measures Participants completed a
baseline questionnaire and were contacted six weeks,
threemonths,and12monthsafter the initial consultation.
Recoverywasassessed in termsof return towork, return to
function, and resolution of pain. The association between
potential prognostic factors and time to recovery was
modelled with Cox regression.
Results The follow-up rate over the 12 months was more
than 97%. Half of those who reduced their work status at
baseline had returned to previous work status within
14 days (95% confidence interval 11 to 17 days) and 83%
had returned to previous work status by three months.
Disability (median recovery time 31 days, 25 to 37 days)
and pain (median 58 days, 52 to 63 days) took much
longer to resolve.Only72%ofparticipantshadcompletely
recovered 12 months after the baseline consultation.
Older age, compensation cases, higher pain intensity,
longer duration of low back pain before consultation,
more days of reduced activity because of lower back pain
before consultation, feelings of depression, and a
perceived risk of persistence were each associated with a
longer time to recovery.
Conclusions In this cohort of patients with acute low back
pain in primary care, prognosis was not as favourable as
claimed in clinical practice guidelines. Recovery was slow
formost patients. Nearly a third of patients did not recover
from the presenting episode within a year.
INTRODUCTION
There is evidence that the type of advice given to
patients can alter the course of an episode of low back
pain. For this reason, most management guidelines
recommend that patients should be reassured that they
have a favourable prognosis. Several guidelines state
that 90% of patients recover within six weeks.1 2 Such
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statements, however, might be too optimistic. While
patients typically improve rapidly, the risk of develop-
ing chronic low back pain (that is, pain persisting for
more than threemonths) is uncertain. Estimates of this
risk vary from 2%3 to 56%.4
To provide individualised advice, it is necessary to
consider prognostic factors.All guidelines for lowback
pain recommend identification of adverse prognostic
factors, commonly described as “yellow flags.”
The lack of consensus regarding the prognosis and
prognostic factors for recent onset low back pain has
been attributed to methodological shortcomings of
previous studies.5-7
Weconductedacohort studywith theprimaryaimof
determining the long term (one year) prognosis for
people with recent onset low back pain presenting to
primary care clinicians. Our secondary aim was to
identify patients’ characteristics that could be readily
assessed by a primary care clinician and were
associated with poor prognosis.
METHODS
The protocol for this study has been published
previously.8 We recruited an inception cohort of 973
participants from a socioeconomically diverse region
in the Sydney metropolitan area of Australia. We
invited all general practitioners, physiotherapists, and
chiropractors within the study area to participate.
Participating clinicians screened all patients with the
primary complaint of low back pain who presented to
their clinics from November 2003 to July 2005.
Low back pain was defined as pain in the area
bounded superiorly by T12 and inferiorly by the
buttock crease, lasting for more than 24 hours but less
than twoweeks, andprecededbyaperiodof at leastone
month without back pain. See bmj.com for exclusions.
The clinicians were given a copy of the most recent
clinical guidelines for lowbackpainandasked to follow
the guidelines when appropriate.
Baseline data were collected at the first consultation
with the primary care clinician. These datawere used to
describe the cohort and to evaluate putative predictors
of outcome. The individual variables were grouped into
seven factors. Low back pain and disability were also
measuredatbaselinewithadaptationsof items7and8of
the SF-36. Clinicians were paid for participating.
Researchers conducted follow-up assessments by
telephone at six weeks, three months, and 12 months
after the initial assessment. We sampled three dimen-
sions of recovery—pain intensity, disability, and work
status—which participants were asked to rate at each
time point. Interviewers also established whether the
patient had recovered on each of these dimensions and
if so the date of recovery.A fourthmeasure of recovery
—“complete recovery”—required the patient to
recover on all three dimensions.
Data analysis—We used the dates on which partici-
pants returned to pre-injury work status and/or had no
disability and/or had no pain to construct survival
curves. Median survival time (days to recovery) was
determined for each of the three recovery measures
individually and for attainment of all three recovery
Cox regressionmodel for time to complete recovery from acute low back pain (LBP) with hazard ratios (HR) and 95%confidence
intervals
Variable
Crude (unadjusted) Adjusted
HR (95% CI) P value HR (95% CI) P value
Age (years) 1.00 (0.99 to 1.00) 0.090 0.99 (0.99 to 1.00) 0.004
Male 1.05 (0.91 to 1.23) 0.500 1.01 (0.86 to 1.18) 0.900
Pain/disability (χ2=31.32, P<0.001)
Pain intensity* 0.79 (0.73 to 0.86) <0.001 0.86 (0.77 to 0.96) 0.009
Interference with function† 0.85 (0.90 to 0.91) <0.001 0.96 (0.88 to 1.05) 0.339
Psychological (χ2=81.51, P<0.001)
Pain control§ 1.04 (1.01 to 1.07) 0.010 1.02 (0.99 to 1.05) 0.267
Tension/anxiety¶ 0.94 (0.91 to 0.96) <0.001 1.02 (0.99 to 1.06) 0.208
Feelings of depression¶ 0.91 (0.89 to 0.93) <0.001 0.94 (0.91 to 0.97) <0.001
Risk of persistence¶ 0.89 (0.87 to 0.92) <0.001 0.92 (0.89 to 0.95) <0.001
Current history (χ2=36.72, P<0.001)
Compensable LBP¶ 0.56 (0.45 to 0.69) <0.001 0.59 (0.47 to 0.74) <0.001
Currently taking medication for LBP 0.75 (0.65 to 0.88) <0.001 0.96 (0.81 to 1.14) 0.657
Days of reduced activity due to LBP¶ 0.96 (0.93 to 0.99) 0.005 1.04 (1.00 to 1.08) 0.033
Leg pain¶ 0.71 (0.59 to 0.86) 0.001 0.90 (0.70 to 1.16) 0.408
No of pain sites‡ 0.83 (0.75 to 0.91) <0.001 0.92 (0.81 to 1.03) 0.147
Duration of episode 0.97 (0.95 to 0.99) 0.030 0.97 (0.94 to 1.0) 0.033
Clinical red flags (not included in model)
No of positive red flags 0.95 (0.91 to 1.00) 0.048 —
*Pain intensity scale: 1=none, 2=very mild, 3=mild, 4=moderate, 5=severe, 6=very severe.
†Disability scale: 1=not at all, 2=little bit, 3=moderate, 4=quite a bit, 5=extreme.
§Rated on scale from 0-10, with higher score indicating better ability to control pain.
¶Rated on scales from 0-10, with higher scores indicating more tension and anxiety, more feelings of depression, or higher risk of persistent pain.
‡One point for each pain site: neck, shoulder, upper back, lower back, and leg.
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measures. We used Cox regression to identify inde-
pendent associations between the seven factors and the
time to complete recovery from acute low back pain.
See bmj.com for further details.
RESULTS
A total of 1254 clinicians in the study region were
identified and contacted. Of these, 170 (73 general
medical practitioners, 77 physiotherapists, and 20
chiropractors) were trained in the study protocol.
They screened3184consecutivepatientswith lowback
pain from November 2003 to July 2005. Of these, 973
patients (mean age 43.3, 54.8%) were eligible to
participate. The follow-up rate remained above 97%
over the 12 month period. Participants for whom we
did not have complete follow-up data and who had not
reported recovery from their low back pain were
censored at the time of their last follow-up.
Full baseline demographic and clinical features of
participants are on bmj.com.We used the participant’s
postcode and data from the Australian census to judge
socioeconomic disadvantage: 21.4% fell in the most
disadvantaged quarter, 8.4% in the second quarter,
14.8% in the third quarter, and 55.1% in the fourth
quarter.
There were 770 (79.5%) participants who reported
working before the onset of their episode of acute low
back pain. Of these, 291 (37.8% of workers, 30.0% of
the total cohort) reported changing their work status as
a result of their low back pain. The median time to
return to previous work hours and duties for these 291
participantswas 14 days (95%confidence interval 11 to
17 days). The cumulative probability of returning to
pre-back pain work hours and duties for those who
reduced their work status at baseline because of low
back pain was 74.6% at six weeks, 83.2% at 12 weeks,
and 89.5% one year after consulting a primary care
clinician for acute low back pain.
The median time to recovery in terms of disability
was 31 days (25 to 37 days). By six weeks the
cumulative probability of having no disability was
54.9%. This probability increased to 73.3% by
12 weeks, and 83.3% by one year. The median time
to recovery in terms of pain after an episode of acute
low back pain was 58 days (53 to 63 days). The
cumulativeprobability of beingpain-freewas39.9%by
six weeks, 58.2% by 12 weeks, and 72.5% by one year.
Complete recovery from recent onset lowback pain,
determined by recovery on all three dimensions
(return to work, no disability, and no pain) took a
median time of 59 days (53 to 65 days). Six weeks after
presentation to primary care, the cumulative prob-
ability of recovery was 39.0%. By 12 weeks the
probability was 57.4%, and this increased to 71.8% by
one year.
At six weeks, three months, and 12 months, 40%,
52%, and 57% of participants reported being pain-free;
60%, 71%, and 75% reported being disability-free.
Immediately before the onset of the episode 77%were
working full time and this reduced to 48% at baseline,
rising to69%, 72%, and72%at sixweeks, threemonths,
and 12 months. At 12 months the participants’
responses to the question “If you had to live with the
symptoms you have right now, how would you feel
about it?” were generally positive, though 133 of the
969 participants reported feeling very dissatisfied and
106 somewhat dissatisfied.
After adjustment for age, sex, intensity of pain, and
interference with function, psychological characteris-
tics were most closely associated with time to recovery
(table). Of the other factors, only factors related to
current history further contributed significantly to the
model. Seven individual variables were independently
associated with time to recovery: age, intensity of pain,
feelingsofdepression, riskofpersistence, lowbackpain
in compensation cases, days of reduced activity, and
duration of the episode.
DISCUSSION
In this study of 12 month prognosis in patients with
recent onset low back pain, recovery was typically
much slower than previously reported. Nearly a third
of patients did not recover from the presenting episode
within a year. Return to work and recovery from
disability and pain did not occur synchronously. We
identified seven factors that were associatedwith speed
of recovery and can be considered by clinicians when
advising their patients about the prognosis for their
episode of acute low back pain.
Strengths and weaknesses
We enrolled an inception cohort from the three main
primary care providers who manage low back pain and
measured pain, disability, and work status over a
12 month period with high rates of follow-up. Our
previous review of prognostic studies of low back pain
found that few studies of acute low back pain have
achieved these benchmarks.6 Socioeconomically disad-
vantaged people were under-represented in the cohort.
Also we did not record participants’ occupation so we
were unable to assess whether this factor influenced the
speed with which people returned to work.
Comparison with other research
There are only a few methodologically sound prog-
nosis studies that have followed patients beyond three
WHAT IS ALREADY KNOWN ON THIS TOPIC
Clinicalpracticeguidelinessuggestthat recovery fromanepisodeof recentonset lowbackpain
is usually rapid and complete
Recent systematic reviews suggest that the risk of developing chronic low back pain is
uncertain
WHAT THIS STUDY ADDS
In this cohort of patients, recovery from recent onset low back painwasmuch slower than has
been reported and nearly a third did not recover within a year
Older age, back pain associated with compensation cases, higher pain intensity, longer
duration of low back pain before consultation, more days of reduced activity because of low
backpainbefore consultation, feelingsofdepression, andaperceived riskofpersistencewere
all associated with poorer prognosis
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months.6 A Danish study also found that recovery was
slow and incomplete.4 In contrast, a French study
reported that recovery was rapid.3 We are unable to
explain themarked difference in results. There are also
difficulties comparingprognostic factorsbetween these
studies. None the less, all three studies report that
compensationcases andhighdisability atbaselinewere
adverse prognostic factors, and our study, and the
French study, report that a previous episode of low
back pain was an adverse prognostic factor. The
Danish study reported that perceived risk of persis-
tence was an adverse prognostic factor,4 but in that
study the clinician judged risk of persistencewhereas in
our study this judgment was made by the patient.
Implications for the guidelines
Our findings support the recommendations in clinical
practice guidelines that clinicians should screen for
adverse prognostic factors (yellow flags). Recovery did
not occur synchronously in the three dimensions of
return to work, interference with function, and pain
status. Pain took the longest to resolve and the survival
curves for recovery from pain and complete recovery
were similar.
There has been little consensus regarding predictors
of outcome from acute low back pain.7 9 Prognostic
information can be used to provide patient specific
estimates of prognosis to individual patients in primary
care.
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Routine care of peripheral intravenous catheters versus
clinically indicated replacement: randomised controlled trial
Joan Webster,1,2 Samantha Clarke,1 Dana Paterson,1 Anne Hutton,1 Stacey van Dyk,1 Catherine Gale,1
Tracey Hopkins1
ABSTRACT
Objective To compare routine replacement of intravenous
peripheral catheterswith replacementonlywhenclinically
indicated.
Design Randomised controlled trial.
Setting Tertiary hospital in Australia.
Participants 755 medical and surgical patients: 379
allocated to catheter replacement only when clinically
indicated and 376 allocated to routine care of catheter
(control group).
Main outcomemeasure A composite measure of catheter
failure resulting from phlebitis or infiltration.
Results Catheters were removed because of phlebitis or
infiltration from 123 of 376 (33%) patients in the control
group compared with 143 of 379 (38%) patients in the
intervention group; the difference was not significant
(relative risk 1.15, 95% confidence interval 0.95 to 1.40).
When the analysis was based on failure per 1000 device
days (number of failures divided by number of days
catheterised, divided by 1000), no difference could be
detected between the groups (relative risk 0.98, 0.78 to
1.24). Infusion related costs were higher in the control
group (mean $A41.02;£19.71;€24.80;$38.55) than
intervention group ($A36.40). The rate of phlebitis in both
groups was low (4% in intervention group, 3% in control
group).
Conclusion Replacing peripheral intravenous catheters
when clinically indicated has no effect the incidence of
failure, based on a composite measure of phlebitis or
infiltration. Larger trials are needed to test this finding
using phlebitis alone as a more clinically meaningful
outcome.
Registration number Australian New Zealand Clinical
Trials Registry ACTRN12605000147684.
INTRODUCTION
Intravenous catheterisation is the most common
invasive procedure among inpatients, with about half
receiving intravenous therapy.1 Between 2.3% and
67% of patients will develop phlebitis.2-8 Despite the
ubiquitous use of catheters and the almost universal
acceptance of the need for routine replacement, the
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of a paper that was published on
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2008;337:a339.
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practice has received little rigorous evaluation. We
therefore carried out a randomised trial to compare
routine changes of catheters with clinically indicated
changes.
METHODS
We recruited inpatients from a general teaching
hospital. Patients were eligible for inclusion if they
were at least 18 years old, had no current bacteraemia,
were not receiving immunosuppressive therapy, and
were scheduled or expected to have a peripheral
venous catheter for at least four days. The patient was
the unit of measurement, therefore we entered those
requiring multiple or consecutive catheters into the
study once only.
We randomised patients either to routine care
(control group), with catheters scheduled to be
replaced every three days according to hospital policy,
or to replacement only when clinically indicated
(clinically indicated group). For each group we
recorded reasons for replacement and deviations
from the replacement protocol.
Participants were randomised by an investigator
with no clinical involvement in the trial. We stratified
by admission for an oncology related procedure. A
research nurse telephoned a contact who was indepen-
dent of the recruitment process for allocation consign-
ment. Clinical staff were subsequently aware of the
treatment group, to ensure that catheterswere changed
as scheduled and that those in the intervention group
were not removed if functional and therewas no sign of
inflammation or infection.
The research nurse collected baseline personal,
clinical, and catheter related data (see bmj.com).
Choice of catheter and gauge was at the discretion of
the professional inserting the catheter. Insertion sites
were inspected daily by a nurse from the intravenous
service and by ward nurses when solutions were
changed or drugs added. To optimise the standardisa-
tion of reporting data, the nurse removing the catheter
recorded the reasons for catheter removal on a
specially designed form.
Any deviations from the protocol for catheter
replacement were recorded. We collected data for up
to five consecutive catheters for each patient.
Outcome measures
For theprimaryoutcomeweused a compositemeasure
of catheter failure as a result of phlebitis or infiltration
(see definitions on bmj.com).
Secondary outcomes included infusion related cost
—those associated with catheters inserted for inter-
mittent administration of intravenous drugs or for
continuous infusion. For patients receiving inter-
mittent drugs we calculated a total cost of $A16.4 per
insertion (see bmj.com) and for those receiving a
continuous infusion we calculated $A28.84 per inser-
tion (see bmj.com).We also included other reasons for
catheter failure as secondary outcomes: occlusion or
blockage, local infectionat the insertion site, or catheter
related bloodstream infection.9 We also included
phlebitis and infiltration as independent secondary
outcomes.
Statistical analysis
Trial data were analysed on an intention to treat basis.
We calculated the relative risks (95% confidence
intervals) for the proportion of patients with a failed
catheter and for the individual factors that made up the
composite measure.We also calculated the failure rate
for eachgroupper1000devicedays (numberof failures
divided by number of days catheterised, divided by
1000), which is a more meaningful measure for this
outcome. When appropriate, we used a two sided
Fisher’s exact test to compare discrete data; results are
presentedasPvalues.Weused the independent sample
t test to compare the differences in the infusion related
costs and total catherisation time between groups.
RESULTS
Overall, 755 of 1620 potentially eligible participants
(46.6%) were included in the trial (see bmj.com): 376
were randomised to routine care of catheters (control
group) and 379 to replacement of catheters only when
clinically indicated (intervention group). Twenty two
participants (6%) in the intervention group had
catheters changed routinely. One hundred and twenty
five participants (33%) in the control group had a
catheter in place for more than 72 hours. Follow-up
from medical records was possible for all participants.
The groups were similar for baseline personal,
clinical, and catheter related characteristics for most
risk factors (see bmj.com). The intervention group had
higher rates for a history of phlebitis and presence of a
wound infection or infected ulcer.
Each catheter was in place for a greater mean length
of time in the intervention group than in the control
group (see bmj.com). As a result more catheters were
placed in the control group (n=749) than in the
intervention group (n=679), despite the average
number of intravenous therapy days being less in the
control group: 6.3 (SD 5.1) in the intervention group
versus 5.4 (SD3.8) in the control group.Thenumber of
days catheterised was 2020 in the control group and
2393 in the intervention group.
Effect of intervention
Overall, 123 (33%) participants in the control group
and 143 (38%) in the intervention group had catheters
removed because of phlebitis or infiltration (table); the
difference was not significant (relative risk 1.15, 95%
confidence interval 0.95 to 1.40). When the analysis
was based on failure per 1000 device hours, no
difference could be detected between the groups.
Infusion related costs per episode of care were higher
in the control group than in the intervention group
(mean $A41.02 vmean$A36.40). Both groups had low
rates of phlebitis (4% in intervention group, 3% in
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control group). Infiltration was the most common
reason for failure (36% in intervention group, 32% in
control group).A total of 196 (26%) catheters in control
participants were replaced after three days, according
to hospital policy, despite functioning well.
DISCUSSION
The routine replacement of peripheral intravenous
catheters has no effect on the incidence of catheter
failure, on the basis of a compositemeasure of phlebitis
or infiltration. The result replicates findings from an
earlier study by us, which used narrower inclusion
criteria but a broader definition of failure.10 These
studies have increased our confidence in changing
intravenous lines according to signs and symptoms,
rather thanusingpredetermined times.11Changingour
policy would bring the practice in adults in line with
recommendations from the Centers for Disease Con-
trol and Prevention for changing peripheral intra-
venous lines in children—that is, replace catheters only
when clinically indicated.
Our overall combined rate for phlebitis and infiltra-
tionwas 35%, similar to other reports.12 13 The phlebitis
rate in both groups was on the low side of ranges
reported in recent studies,14 15 despite our population
being elderly and almost 75% having at least one
comorbidity. Reported rates depend on definitions
used, and although we applied a standard definition,
interpretation of signs and symptoms could be affected
by subjectivity or omission of reporting. It is perhaps
moreuseful touse the compositemeasureof infiltration
or phlebitis to avoid misdiagnosis.
Despite group allocation, participants showed little
difference indwell times.Two factors contribute to this.
Firstly, it is not possible to modify all routinely
scheduled changes precisely 72 hours after insertion.
Secondly, many of the catheters in the intervention
group failed before 72 hours—although catheters
remained in place longer than in the control group,
the average dwell time was within the 72-96 hours
recommended by the Centers for Disease Control and
Prevention. This confirms that all catheters fail
eventually but that many remain functional for
prolonged periods (about 3% remained trouble free
for over seven days and some for as long as twoweeks).
We therefore believe that routinely changing catheters
may be an unnecessary, painful, and costly inter-
vention.
Potential cost savings of about 25% for infusion
related costs could be made if our policy was to be
changed in line with recent evidence. Cost estimates
used in our studywere conservative, based on a simple
intravenous event.
The study was not sufficiently powered to show
differences inour secondary clinical outcomes.Despite
this, non-significant results favoured the control group
for lower rates of phlebitis, blockage, and local
infection.
Strengths and limitations
The major strengths of the study were the processes
used to eliminate selection bias, ensure allocation
concealment, and ensure that the studywas adequately
powered to detect differences in our primary outcome.
We also included a range of participants and did not
impose caveatsonhoworbywhomcatheters shouldbe
inserted. This was to match normal practice and to
enable the extrapolation of results to other inpatient
populations. We enrolled 47% of eligible patients
Outcomes for patients allocated to routine care of intravenous catheter (control group) or to replacement of catheter only when
clinically indicated (intervention group). Values are numbers (percentages) of patients unless stated otherwise
Outcomes
Intervention group
(n=379)
Control group
(n=376)
Relative risk
(95% CI)
Primary:
Catheter failure per person 143 (38) 123 (33) 1.15 (0.95 to 1.40)
Catheter failure per 1000 device days 59.8 60.9
Secondary:
Mean (SD) intravenous cost per catheter 41.05 (26.6) 46.22 (28.7) −5.16* (−9.12 to −1.21)
Phlebitis 16 (4) 12 (3) 1.32 (0.63 to 2.76)
Infiltration 135 (36) 120 (32) 1.12 (0.91 to 1.36)
Blockage 30 (8) 20 (5) 1.49 (0.86 to 2.57)
Local infection 2 (1) 0 4.96 (0.24 to 102.98)
Suspected bloodstream infection 1 (0.3) 1 (0.3) 0.99 (0.06 to 15.80)
*Mean difference.
WHAT IS ALREADY KNOWN ON THIS TOPIC
Peripheral intravenous catheterisation is the most common
invasive procedure among inpatients
Changing catheters every three days to prevent infection is
standard procedure but the practice has not been rigorously
tested
WHAT THIS STUDY ADDS
Cathetersmaybesafely left in place for longer than72hours
if no contraindications are present
When catheters are replaced only when clinically indicated
25% of infusion related costs are saved
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compared with about 25% in the earlier trial, with no
losses to follow-up.
The study would have been strengthened if
monitoring of outcomes had been more stringent.
As it was, we extractedmost of the outcome data from
medical records. A more standardised approach
would have been preferable, using staff trained in
the process and data collected in real time. Also,
outcome assessment was done by people who were
not blinded to group allocation. Although catheters
were removed by ward or intravenous service staff,
part of their normal practice is to record reasons for
removal in the patient’s medical record. To falsify
records because of group allocation would be
unlikely. Finally, the study was not powered to
study differences in secondary outcomes. Phlebitis
alone would have been a more clinically important
end point but we were limited by funding.
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Bullous pemphigoid and pemphigus vulgaris—incidence
and mortality in the UK: population based cohort study
S M Langan,1 L Smeeth,2 R Hubbard,3 K M Fleming,3 C J P Smith,3 J West3
ABSTRACT
Objective To determine the incidence of and mortality
from bullous pemphigoid and pemphigus vulgaris in the
United Kingdom.
Design Retrospective historical cohort study.
Setting Computerised medical records from the health
improvement network, a large population based UK
general practice database.
Participants Patients with pemphigus vulgaris and
bullous pemphigoid diagnostic codes and age, sex, and
practice matched controls.
Mainoutcomemeasures Incidenceandmortality compared
with the control population by calendar period, age group,
sex, geographical region, and degree of social deprivation.
Results 869 people with bullous pemphigoid and 138
people with pemphigus vulgaris were identified. The
median age at presentation for bullous pemphigoid was
80 (range 23-102) years, and 534 (61%) patients were
female. The median age at presentation for pemphigus
vulgaris was 71 (21-102) years, and 91 (66%) patients
were female. Incidences of bullous pemphigoid and
pemphigusvulgariswere4.3 (95%confidence interval 4.0
to 4.6) and 0.7 (0.6 to 0.8) per 100000 person years. The
incidence of bullous pemphigoid increased over time; the
average yearly increase was 17% (incidence rate
ratio=1.2, 95% confidence interval 1.1 to 1.2). An average
yearly increase in incidence of pemphigus vulgaris of 11%
(incidence rate ratio=1.1, 1.0 to 1.2) occurred. The risk of
death for patients with bullous pemphigoid was twice as
great as for controls (adjusted hazard ratio=2.3, 95%
confidence interval 2.0 to 2.7). For pemphigus vulgaris,
the risk of death was three times greater than for controls
(adjusted hazard ratio=3.3, 2.2 to 5.2).
Conclusions Incidences of bullous pemphigoid and
pemphigus vulgaris are increasing. The reasons for the
changes in incidence are not clearly understood but have
implications for identifying causative factors. Both
disorders are associated with a high risk of death.
Previous estimates may have underestimated the risk of
death associated with these diseases.
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INTRODUCTION
Previous studies of bullous pemphigoid have reported
incidencesbetween0.2 and3per100 000personyears;
these are higher in older age groups, and some studies
report associations with sex.1-4 Wide variation in
mortality is reported, with one year mortality varying
between 6% in the United States and 41% in France.5 6
Hospital based studies of the epidemiology of
pemphigus vulgaris report incidence varying between
0.076and1.6per100000personyears.78 Several studies
have suggested a higher incidence in women.89 Two
studies report one year mortality of 4.8% and 54%, with
no clear estimate of overall disease specificmortality.1011
The published studies are mainly small and hospital
based.Wecarried out a large populationbased study in
people with bullous pemphigoid and pemphigus
vulgaris toprovidedata on incidence anddemographic
data in the UK and to resolve controversies about
mortality from these autoimmune disorders, which
cause blistering of the skin and mucous membranes.
METHODS
The health improvement network is a computerised
longitudinal general practice database with demo-
graphic data similar to the general population. The
version we used contained data from 328 general
practices that use “In Practice Vision” software. The
quality of the data has been validated.12
Study population
Between 1996 and 2006, we identified all patients with
a diagnosis of bullous pemphigoid or pemphigus
vulgaris from the health improvement network data-
base. In order to exclude prevalent cases,we imposed a
lag period of three months after registration with their
general practitioner to differentiate between incident
and prevalent cases.We selected a control group of up
to four controls per case, matched randomly by age,
sex, and general practice, and contributing data to the
database. We excluded people aged under 20 years.
We assigned a date of “pseudodiagnosis” to controls,
which was the date of diagnosis for the matched case.
Outcomes
We recorded incident diagnoses and dates of death.
The follow-up period began on the date of first
diagnosis or “pseudodiagnosis.”
Statistical analysis
Incidence—We calculated incidences by age, cate-
gorised into 10 year age bands; sex; and calendar
period. We used multivariate regression to model
incidence rate ratios, adjusting for changes in age, sex
structure, and calendar period over time. We applied
calculated incidences for both diseases to the UK
population totals for the years 2001-5 to estimate the
number of new cases a year.
Mortality—We identified all deaths in the two case
populations and matched controls and calculated one
year mortality and five year survival rates. We used
Cox regression to compare the mortality of cases and
controls, adjusting for age, sex, and calendar period.
Office for National Statistics data—We calculated
expected numbers of incident cases and deaths for
both diseases by applying study rates to the Office for
National Statistics population (2001-5) and comparing
results with Office for National Statistics data.
RESULTS
Our cohort included 869 people with bullous pemphi-
goid contributing1993personyears and3453matched
controls contributing 9765 person years. The median
age at first presentation for bullous pemphigoid was 80
(range 23-102) years, and 534 (61%) patients were
women. One hundred and thirty eight people with
pemphigus vulgaris contributed 380 person years, and
551 matched controls contributed 1763 person years.
The median age at first presentation for pemphigus
vulgaris was 71 (21-102) years, and 91 (66%) patients
were women. The median length of follow-up for
people with bullous pemphigoid was 1.6 (range 0-9)
years, and that for pemphigus vulgaris was 2.0 (0-10.4)
years. Losses to follow-up were similar in cases and
controls in both diseases (by the end of year 2, bullous
pemphigoid cases and controls 34% lost; pemphigus
vulgaris cases 30% lost, controls 31% lost).
Bullous pemphigoid
Incidence—The crude incidence of bullous pemphigoid
was 4.28 (95% confidence interval 4.01 to 4.58) per
100 000personyears. Incidence increasedwithageand
in later calendar periods (figure). The increased
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Bullous pemphigoid
Pemphigus vulgaris
Age adjusted rates of bullous pemphigoid and pemphigus
vulgaris, with direct standardisation to European standard
population
Crude and adjusted survival analysis for patientswith bullous pemphigoid and pemphigus
vulgaris
Deaths Person years
Crude hazard ratio
(95% CI)
Adjusted hazard ratio
(95% CI)
Bullous pemphigoid
Controls 604 9765 1.0 1.0
Cases 264 1993 2.11 (1.82 to 2.44) 2.29 (1.98 to 2.65)
Pemphigus vulgaris
Controls 58 1763 1.0 1.0
Cases 36 380 2.82 (1.86 to 4.27) 3.38 (2.21 to 5.17)
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incidenceover calendar timepersistedafter adjustment
for age group and sex (P for trend <0.0001). The
estimated increase in the incidence of bullous pemphi-
goid per increase in calendar year was 17% (rate ratio
1.17, 95% confidence interval 1.14 to 1.20; P<0.0001)
after adjustment for sex and age group, corresponding
to a 4.8-fold increase in incidence over the 11 year
period or a crude increase of 5.2-fold during the study.
Applying this data to theUKpopulation between 2001
and 2005 gave an average of 2996 (95% confidence
interval 2485 to 3602) new cases a year.
Mortality—The table shows mortality for the bullous
pemphigoid cohort. The overall crude mortality was
131.99 (95% confidence interval 116.96 to 148.95) per
1000 person years for bullous pemphigoid and 61.86
(57.12 to 66.99) per 1000personyears for controls.The
absolute excess mortality in the bullous pemphigoid
cohort was 70 per 1000 person years. The one year
mortality for bullous pemphigoid was 19% (95%
confidence interval 16.2% to 21.8%). The table shows
crude and adjusted hazard ratios. We found no
evidence of effect modification by calendar time.
Pemphigus vulgaris
Incidence—The crude incidence of pemphigus vulgaris
was 0.68 (0.58 to 0.80) per 100 000 person years.
Incidence was higher in women and in older age
groups. We found evidence of an estimated 11%
increase in incidence per calendar year (incidence rate
ratio 1.11 (1.04 to 1.17) per year; P=0.001) (figure).We
saw a slight reduction in incidence in the most recent
period from3.5 (1.9 to6.2) in2002-4 to2.4 (1.2 to4.5) in
2005-6. Applying these data to the UK population
between 2001 and 2005 gave an average of 467 (297 to
643) new cases of pemphigus vulgaris a year.
Mortality—The table shows mortality for the pem-
phigusvulgaris cohort.Theoverall crudemortalitywas
94.64 (68.268 to 131.205) per 1000 person years for
pemphigus vulgaris and 32.89 (25.43 to 42.55) per
1000 person years for controls. The absolute excess
mortality in the pemphigus vulgaris cohort was 62 per
1000 person years. The one year mortality for
pemphigus vulgaris was 12% (8% to 19%). The table
shows crude and adjusted hazard ratios.
Comparison with Office for National Statistics mortality
data
Applying themortality data to the UK population data
gave 1977 deaths in bullous pemphigoid cases and 221
deaths in pemphigus vulgaris cases (2001-5). These are
much higher figures than the 190 and 36 deaths
attributed to these diseases in the Office for National
Statistics dataset.
DISCUSSION
Wefounda substantial increase in the incidenceofboth
bullous pemphigoid and pemphigus vulgaris between
1996 and 2005. This increase was not associated with
any reduction in mortality over the calendar periods
and is therefore unlikely to be explained by ascertain-
ment bias leading to the diagnosis of less severe cases.
Our study therefore suggests that almost 3000 new
cases of bullous pemphigoid and 500 of pemphigus
vulgaris occur each year. Age and sex adjusted
mortality was more than twice as high in people with
bullous pemphigoid compared with the general
population and three times as high in those with
pemphigus vulgaris. The reported mortality for
bullous pemphigoid increased from 63 to 88 per 1000
person years between 2001 and 2005, and that for
pemphigus vulgaris increased from 13 to 19 per 1000
person years.
Strengths and weaknesses
This is a large, population based study, which allows
robust estimation of incidence and mortality. The size
of the dataset gives sufficient power to exclude chance
as the basis for the findings. The use of routinely
collected data means that we could not validate the
diagnoses or assess severity of disease. Thesediagnoses
are made in secondary care, and therefore likely to be
accurate. Previous studies of other conditions have
confirmed the validity of diagnoses in both the general
practice research database and the health improve-
ment network. Limiting the dataset to practices
considered “up to standard” will have improved the
quality. Some of the cases included may be prevalent
rather than incident cases—if this is the case, the results
may be affected by survival bias and we may have
underestimated the mortality associated with these
diseases.
Comparison with other studies
The mean age of patients with bullous pemphigoid in
our study is similar to other published data. However,
with the exception of one regional study, all studies
werehospital based; therefore, although theymayhave
had excellent validity, they may be less representative
of the disease in the population. The mean age of
patients with pemphigus vulgaris in our study was
much higher than previous reports. However, no data
on the epidemiology of pemphigus vulgaris in western
Europe have been published and all of the studies are
from hospital centres in the form of either cross
sectional surveys or case series.
WHAT IS ALREADY KNOWN ON THIS TOPIC
Little is known about the epidemiology of bullous pemphigoid and pemphigus vulgaris
Bullous pemphigoid is known to be associated with high mortality; mortality of pemphigus
vulgaris in western Europe is not known
WHAT THIS STUDY ADDS
The incidencesofbullouspemphigoidandpemphigus vulgaris are increasing, but the reasons
for this are not clear
Mortality of bullous pemphigoid is twice that of the general population, and mortality of
pemphigus vulgaris is three times as high as in the general population
Previous measures may have underestimated the burden of these diseases, in terms of both
incidence and risk of death
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The incidence of bullous pemphigoid in our study
is similar to that described by others2; the incidence
of pemphigus vulgaris is within the range of the
previous papers, and the sex distribution is also
similar.8-10 The increasing trend in incidence of
bullous pemphigoid has not been previously
shown. A possible explanation is increased ascer-
tainment, but if this is the case the increasing trend
has not levelled off.
One year mortality from bullous pemphigoid is
19%, intermediate between that described in the
United States (11%) and Europe (25-41%).2 4-6 13 One
year mortality for pemphigus vulgaris is higher than
that described in a study in Turkey (4.8%) but lower
than that in a study from theUnited States (54%;mean
age of cases not given).10 11 The designs used in both of
these studies are susceptible to selection bias, and
drawing robust conclusions from the findings is
difficult.
Interpretation and implications
Our study shows that rates of bullous pemphigoid
seem to be increasing over time. Rates of pemphigus
vulgaris are increasing to a lesser degree despite the
facts that both disorders are more common with
increasing age and that the multivariate analysis was
adjusted for age. Possible explanations include ascer-
tainment bias, misclassification, and a true increase in
incidence. Our study has also shown high mortality
associated with these diseases.
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Drips, drains, and dressings
After a restless night at home with increasing abdominal
pain, followed by bilious vomiting in casualty and an
ultrasound scan that showed “a thick-walled gall-bladder
with multiple stones, some impacted in the neck,” the
diagnosis of cholecystitis was obvious.
So,my infrequent episodes over 20 years of retrosternal
pains and unrelated rigors diagnosed by me as due to
oesophageal spasm and viral infections had been nothing
of the sort. How unsurprising—doctors who treat
themselves have fools as patients.
Withmyminimal rightupperquadrant tendernessanda
neutrophil count of 14 000, treatment was also obvious:
intravenous antibiotics and remove the offending organ in
six weeks’ time.
An unpleasant week in hospital followed, largely
because of the illness but compounded by poor
communication, perfunctory examinations, and a
misleadingly normal temperature chart (but then
temperature goes up after a rigor and not at the time).
It was great to go home, but five days later, after hours of
rigors, Iwas back in casualty on a Fridaynight. This time, a
thorough history and examination was conducted by the
on-call surgical registrar. My minimal abdominal
tenderness and neutrophil count of 21 000 resulted in
intravenous antibiotics being recommenced and, in the
morning, a visit from the on-call consultant.
Like his registrar, the consultant had plenty of time to
take a full history and make a thorough examination.
Some fullness over the gallbladder areawas noted, and the
first thought was to continue intravenous treatment—but
wait. Rigors a few days after antibiotics, a rising neutrophil
count, and some abnormality on examination led to a
rethink: “Well, you don’t look ill enough and should have
more tenderness to have an empyema, but how else to
explain the developing picture?” And thank heavens for
that time honoured surgical aphorism, “If in doubt, cut it
out.”
The findings: gallbladder stuck to colonandduodenum,
thick walled in part, but thin and friable in others,
containing multiple stones, some impacted in the neck—
and containing 150 ml of pus.
So perhaps for me, postponement of a failed
interview with the heavenly choir. And for all of us;
don’t be slavishly led by test results, but allow them to do
their job in building up the complete clinical picture.
Thank you to the on-call surgeons for taking the time to
listen.
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